Phase II Study of Digoxin in Combination with FOLFIRINOX in Patients with Resectable Pancreatic Cancer
The purpose of this phase II study is to evaluate the safety and efficacy of digoxin in combination with FOLFIRINOX in patients with resectable pancreatic cancer.
Study ID: 668-19
Trial Phase: Phase II
Trial Sponsor: Jean Grem, MD
Therapies Used in This Trial: FOLFIRINOX, Digoxin